Omeros OMER
NASDAQ OMER
$18.47 -0.57 (-2.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Omeros (OMER) Return on Equity [ROE] (2011 - 2023)

Updated

Omeros' Return on Equity [ROE] came in at -388.17% for FY2023, down 474.81 percentage points from 86.63% in FY2022.

Analysis

Omeros (OMER) Return on Equity [ROE] (2011 - 2023) Analysis & Trends

Going back to FY2010, Omeros' Return on Equity [ROE] data covers 4 years.

  • The FY2023 figure represents the lowest annual Return on Equity [ROE] since FY2011.
  • Per Business Quant, earlier years put Return on Equity [ROE] at 86.63% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Omeros 1.37 Bn 1.37 Bn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 609.58%
Jun 30, 2023 106.78%
Mar 31, 2023 66.46%
Dec 31, 2022 240.88%
Mar 31, 2022 2,082.35%
Dec 31, 2017 -1,717.21%
Jun 30, 2015 -503.45%
Sep 30, 2011 -393.40%
API Access

Omeros Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OMER&period=max&api_key=YOUR_API_KEY